Skip to content
OpenCapital
Get started

Pediatrix Medical Group MD Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Progyny logo
ProgynyPGNY
——

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×—
P/S1×+0.3×

Profitability

See full
Operating margin11.3%—
Net margin9%—
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%—
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's available for sale securities debt securities current?
Pediatrix Medical Group (MD) reported available for sale securities debt securities current of $123.19M in Q1 2026.
How has Pediatrix Medical Group's available for sale securities debt securities current changed year-over-year?
Pediatrix Medical Group's available for sale securities debt securities current increased by 2.5% year-over-year, from $120.2M to $123.19M.
What is the long-term trend for Pediatrix Medical Group's available for sale securities debt securities current?
Over 5 years (2020 to 2025), Pediatrix Medical Group's available for sale securities debt securities current has grown at a 3.5% compound annual growth rate (CAGR), from $104.87M to $124.48M.